VYRIAD INC

Where Therapies Go Viral

VYRIAD INC is a biotech company in Rochester, United States, founded in 2017. It has raised $124.5M across 3 rounds, most recently an $85.0M Series B in December 2025.

Employees
11–50
Founded
2017
Business Model
B2B
Website
vyriad.com
Total Funding
$124.5M
Last Round
$85.0M Series BDec 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. to use credits for reveals, or explore the API.

About

Vyriad is a clinical-stage biotechnology company founded by Mayo Clinic scientists developing engineered virus platforms for oncolytic virotherapy, in vivo gene therapy, and gene editing. The company's VSV and measles virus-based therapies are in Phase 1-2 clinical trials across multiple cancer types, with an ongoing strategic collaboration with Regeneron Pharmaceuticals.

Funding History

Data from Indexed.vcUpdated
Series BSeries BDec 2025
$85.0M

2 more funding events

  • Series B2022
  • Series A2017

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×2
  • Backend ×1
  • Frontend ×1
  • Productivity & Collaboration ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020
Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech
Series BTotal funding$832.0MSep 2025
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech
Private EquityTotal funding$607.0MJan 2024
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

VYRIAD INC on Indexed.vc
<a href="https://indexed.vc/companies/vyriad-inc"><img src="https://indexed.vc/api/badge/company/vyriad-inc" alt="VYRIAD INC on Indexed.vc" width="260" height="76" /></a>